Table of Contents
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Asia-Pacific Glaucoma Treatment Market, by Disease Indication
5.1 Introduction
5.1.1 Closed Angle Glaucoma (CAG)
5.1.2 Open Angle Glaucoma (OAG)
5.1.3 Secondary Glaucoma
5.1.4 Congenital Glaucoma
5.1.5 Other
6 Asia-Pacific Glaucoma Treatment Market, by Drug class
6.1 Introduction
6.1.1 Prostaglandin Analogs (PGAs)
6.1.2 Alpha Agonist
6.1.3 Beta Blockers
6.1.4 Cholinergic Drugs
6.1.5 Carbonic Anhydrase Inhibitors
6.1.6 Others
7 Asia-Pacific Glaucoma Treatment Market, by Surgery
7.1 Introduction
7.1.1 Laser Iridotomy
7.1.3 Laser Trabeculoplasty
7.1.4 Aqueous Shunt Surgery
7.1.5 Peripheral Iridectomy
8 Asia-Pacific Glaucoma Treatment Market, by End Users
8.1 Introduction
8.1.1 Hospitals
8.1.3 Home Users
9 Africa Medical Devices Market, by Country
9.1 Introduction
9.2 Japan
9.3 China
9.4 India
9.5 Australia
9.6 Kazakhstan
9.7 Rest of Asia Pacific
10 Company Landscape
10.1 Introduction
10.1.1 Mergers Acquisitions
10.1.2 Collaborations
10.1.3 Release/New Product Launches
10.1.4 Other (Expansion, Updates, Partnership)
11 Company Profile
11.1 Novartis AG
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financials
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Pfizer Inc.
11.2.1 Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financials
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Allergan
11.3.1 Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financials
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.4 Merck & Co.
11.4.1 Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financials
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 Ocular Therapeutix Inc
11.5.1 Overview
11.5.2 Product/Business Segment Overview
11.5.3 Financials
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 pSivida Corp
11.6.1 Overview
11.6.2 Product/Business Segment Overview
11.6.3 Financials
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Icon Bioscience Inc.
11.7.1 Overview
11.7.2 Product/Business Segment Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Amorphex Therapeutics LLC.
11.8.1 Overview
11.8.2 Product/Business Segment Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Ellex
11.9.1 Overview
11.9.2 Product/Business Segment Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Quantel
11.10.1 Overview
11.10.2 Product/Business Segment Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Lumenis
11.11.1 Overview
11.11.2 Product/Business Segment Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Lightmed
11.12.1 Overview
11.12.2 Product/Business Segment Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Others
12 Appendix
List of Tables
TABLE 1 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, 2020-2027 (USD MILLION)
TABLE 2 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY DISEASE INDICATION, 2020-2027 (USD MILLION)
TABLE 3 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY DRUG CLASS, 2020-2027 (USD MILLION)
TABLE 4 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY SURGERY, 2020-2027 (USD MILLION)
TABLE 5 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 6 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY DISEASE INDICATION
FIGURE 4 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY DRUG CLASS
FIGURE 5 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY SURGERY
FIGURE 6 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY END USERS
FIGURE 7 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET, BY REGION
FIGURE 8 ASIA-PACIFIC GLAUCOMA TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
